A Weitnauer team led by Prof. Dr. Hans-Eric Rasmussen-Bonne has comprehensively advised Altavo GmbH, Dresden, on its EUR 5 mio. Series A financing round with a European consortium. The financing round was led by OCCIDENT with the participation of bm-t beteiligungsmanagement thüringen GmbH, Novalis Biotech and TGFS Technologiegründerfonds Sachsen III as well as the existing investors High-Tech Gründerfonds III, TGFS Basic, TUDAG, Saxonia Systems Holding GmbH and various already invested business angels. The funds raised will be used for the further technical and clinical development of the artificial voice.

Berlin based corporate partner Prof. Dr. Hans-Eric Rasmussen-Bonne has been advising Altvao GmbH since its seed round in 2021.

About Altavo:

Altavo GmbH is a medical technology startup founded in February 2021 and based in Dresden. Based on non-invasive radar sensor technology and artificial intelligence, Altavo develops prosthetics to improve the rehabilitation of voiceless and vocally impaired patients. Altavo currently employs 15 people at its Dresden and Jena sites with many years of experience in the fields of AI / data science, speech technology, high-frequency technology, medical technology and voice therapy.